Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MALIGNANT NEUROLEPTIC SYNDROME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 361 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McCall, WV
      Electroconvulsive thera in the era of modern psychopharmacology

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Segal, J; Isaacs, MD; Berk, M
      Neuroleptic malignant syndrome: Possible induction by olanzapine in a casewith relapsing catatonia

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    3. Malur, C; Francis, A
      Emergence of catatonia during ECT

      JOURNAL OF ECT
    4. Aziz, M; Maixner, DF; DeQuardo, J; Aldridge, A; Tandon, R
      ECT and mental retardation: A review and case reports

      JOURNAL OF ECT
    5. Malur, C; Pasol, E; Francis, A
      ECT for prolonged catatonia

      JOURNAL OF ECT
    6. Reeves, RR; Mack, JE; Torres, RA
      Neuroleptic malignant syndrome during a change from haloperidol to risperidone

      ANNALS OF PHARMACOTHERAPY
    7. Shiloh, R; Weizman, A; Epstein, Y; Rosenberg, SL; Valevski, A; Dorfman-Etrog, P; Wiezer, N; Katz, N; Munitz, H; Hermesh, H
      Abnormal thermoregulation in drug-free male schizophrenia patients

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    8. Hermesh, H; Manor, I; Shiloh, R; Weizman, R; Munitz, H
      Absence of myoglobinuria in acute psychotic patients with marked elevationin serum creatine phosphokinase level

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    9. Arnaout, MS; Antun, FP; Ashkar, K
      Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    10. Muqit, MMK; Rakshi, JS; Shakir, RA; Larner, AJ
      Catatonia or abulia? A difficult differential diagnosis

      MOVEMENT DISORDERS
    11. Kalant, H
      The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    12. Angelini, G; Ketzler, JT; Coursin, DB
      Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit

      CRITICAL CARE CLINICS
    13. Burns, MJ
      The pharmacology and toxicology of atypical antipsychotic agents

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    14. Kubo, S; Orihara, Y; Kitamura, O; Ikematsu, K; Tsuda, R; Nakasono, I
      An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria

      FORENSIC SCIENCE INTERNATIONAL
    15. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
      Response of catatonia to risperidone: Two case reports

      CLINICAL NEUROPHARMACOLOGY
    16. Fink, M
      Catatonia: syndrome or schizophrenia subtype? Recognition and treatment

      JOURNAL OF NEURAL TRANSMISSION
    17. Teter, CJ; Guthrie, SK
      A comprehensive review of MDMA and GHB: Two common club drugs

      PHARMACOTHERAPY
    18. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    19. Turner, MR; Gainsborough, N
      Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen

      JOURNAL OF PSYCHOPHARMACOLOGY
    20. Wappler, F
      Malignant hyperthermia

      EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    21. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    22. Rhoney, DH; Parker, D
      Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology

      NEUROLOGICAL RESEARCH
    23. Hodge, CH; Jewell, M; Gummin, DD; Leikin, JB
      Atypical presentation of risperidone toxicity

      VETERINARY AND HUMAN TOXICOLOGY
    24. Gracious, BL; Findling, RL
      Antipsychotic medications for children and adolescents

      PEDIATRIC ANNALS
    25. Susman, VL
      Clinical management of neuroleptic malignant syndrome

      PSYCHIATRIC QUARTERLY
    26. Libenson, MH; Lev, MH; Yang, JM; Mark, EJ
      A 16-year-old boy with an altered mental status and muscle rigidity. Strychnine poisoning. Bipolar disease.

      NEW ENGLAND JOURNAL OF MEDICINE
    27. Frey, R; Schreinzer, D; Heiden, A; Kasper, S
      Electroconvulsive therapie

      NERVENARZT
    28. Ueda, M; Hamamoto, M; Nagayama, H; Okubo, S; Amemiya, S; Katayama, Y
      Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    29. Goff, ML
      Protecting our mentally ill: A critique of the role of Indiana state courts in protecting involuntarily committed mental patients' right to refuse medication

      INDIANA LAW JOURNAL
    30. Velickovic, M; Benabou, R; Brin, MF
      Cervical dystonia - Pathophysiology and treatment options

      DRUGS
    31. Bhana, N; Foster, RH; Olney, R; Plosker, GL
      Olanzapine - An updated review of its use in the management of schizophrenia

      DRUGS
    32. Nisijima, K; Yoshino, T; Yui, K; Katoh, S
      Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

      BRAIN RESEARCH
    33. Walter, S; Rey, JM; Dekker, F
      The humble case report

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    34. Thorley, RR; Wertsch, JJ; Klingbeil, GE
      Acute hypothalamic instability in traumatic brain injury: A case report

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    35. Tanvetyanon, T; Dissin, J; Selcer, UM
      Hyperthermia and chronic pancerebellar syndrome after cocaine abuse

      ARCHIVES OF INTERNAL MEDICINE
    36. Gerbershagen, MU; Ito, WD; Wappler, F; Fiege, M; Esch, JSA
      Neuroleptic malignant syndrome after haloperidol application

      ANAESTHESIST
    37. Onofrj, M; Thomas, A; Bonanni, L; Iacono, D; Gambi, F
      Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine

      NEUROLOGICAL SCIENCES
    38. Bhana, N; Spencer, CM
      Risperidone - A review of its use in the management of the behavioural andpsychological symptoms of dementia

      DRUGS & AGING
    39. McDonald, WM; Greenberg, BD
      Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry

      DEPRESSION AND ANXIETY
    40. Worrel, JA; Marken, PA; Beckman, SE; Ruehter, VL
      Atypical antipsychotic agents: A critical review

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    41. Elliott, ESR; Marken, PA; Ruehter, VL
      Clozapine-associated extrapyramidal reaction

      ANNALS OF PHARMACOTHERAPY
    42. Gregorakos, L; Thomaides, T; Stratouli, S; Sakayanni, E
      The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome

      CLINICAL AUTONOMIC RESEARCH
    43. Henderson, MJ; Mellers, JDC
      Psychosis in Parkinson's disease: 'between a rock and a hard place'

      INTERNATIONAL REVIEW OF PSYCHIATRY
    44. Wirshing, DA; Erhart, SM; Pierre, JM; Boyd, JA
      Nonextrapyramidal side effects of novel antipsychotics

      CURRENT OPINION IN PSYCHIATRY
    45. Spivak, B; Maline, DI; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Weizman, A
      Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow

      EUROPEAN PSYCHIATRY
    46. Kunishima, Y; Masumori, N; Kadono, M; Tsukamoto, T
      A case of neuroleptic malignant syndrome in a patient with hemodialysis

      INTERNATIONAL JOURNAL OF UROLOGY
    47. Nemets, B; Geller, V; Grisaru, N; Belmaker, RH
      Olanzapine treatment of clozapine-induced NMS

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    48. Stanfield, SC; Privette, T
      Neuroleptic malignant syndrome associated with olanzapine therapy: A case report

      JOURNAL OF EMERGENCY MEDICINE
    49. David, WS
      Myoglobinuria

      NEUROLOGIC CLINICS
    50. Chong, SA; Remington, G
      Clozapine augmentation: Safety and efficacy

      SCHIZOPHRENIA BULLETIN
    51. Yoshikawa, H; Watanabe, T; Abe, T; Oda, Y; Ozawa, K
      Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child

      BRAIN & DEVELOPMENT
    52. Radomski, JW; Dursun, SM; Reveley, MA; Kutcher, SP
      An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria

      MEDICAL HYPOTHESES
    53. Green, B
      Focus on risperidone

      CURRENT MEDICAL RESEARCH AND OPINION
    54. Sechi, G; Agnetti, V; Masuri, R; Deiana, GA; Pugliatti, M; Paulus, KSM; Rosati, G
      Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    55. Nisijima, K
      Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    56. O'Halloran, RL; Frank, JG
      Asphyxial death during prone restraint revisited - A report of 21 cases

      AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY
    57. Otani, K; Aoshima, T
      Pharmacogenetics of classical and new antipsychotic drugs

      THERAPEUTIC DRUG MONITORING
    58. Cook, JD; Caplan, YH; LoDico, CP; Bush, DM
      The characterization of human urine for specimen validity determination inworkplace drug testing: A review

      JOURNAL OF ANALYTICAL TOXICOLOGY
    59. Dev, V; Raniwalla, J
      Quetiapine - A review of its safety in the management of schizophrenia

      DRUG SAFETY
    60. Stanniland, C; Taylor, D
      Tolerability of atypical antipsychotics

      DRUG SAFETY
    61. Noel, F; Geurts, M; Maloteaux, JM
      Selective destruction of nigrostriatal dopaminergic neurons does not alter[H-3]-ryanodine binding in rat striatum

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    62. Keck, PE; Arnold, LM
      The serotonin syndrome

      PSYCHIATRIC ANNALS
    63. Jenkins, DH
      Substance abuse and withdrawn in the intensive care unit - Contemporary issues

      SURGICAL CLINICS OF NORTH AMERICA
    64. Calvo-Romero, JM; Bonilla-Gracia, MD; Ramos-Salado, JL; Bureo-Dacal, P
      Rigidity, hyperthermia, and altered mental status

      POSTGRADUATE MEDICAL JOURNAL
    65. Behan, WMH; Madigan, M; Clark, BJ; Goldberg, J; McLellan, DR
      Muscle changes in the neuroleptic malignant syndrome

      JOURNAL OF CLINICAL PATHOLOGY
    66. Pierantozzi, M; Sabato, AF; Leonardis, F; Marciani, MG; Cicardi, C; Giacomini, P; Bernardi, G; Stanzione, P
      Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes

      EXPERIMENTAL BRAIN RESEARCH
    67. Fujikawa, TG; Itabashi, HH; Wu, AG; Shinmei, SS
      Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy

      EPILEPSIA
    68. Malur, C; Fink, M; Francis, A
      Can delirium relieve psychosis?

      COMPREHENSIVE PSYCHIATRY
    69. Cavagna, D; Zorzato, F; Babini, E; Prestipino, G; Treves, S
      Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca2+ release channel

      BRITISH JOURNAL OF PHARMACOLOGY
    70. Esler, MD; Pratt, ME; Brunner, MD
      Postoperative orphenadrine withdrawal

      BRITISH JOURNAL OF ANAESTHESIA

    71. PART A: Background information and treatment recommendations for patients with HIV/AIDS - Introduction

      AMERICAN JOURNAL OF PSYCHIATRY
    72. Spivak, B; Maline, DI; Vered, Y; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Graff, E; Weizman, A
      Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome

      ACTA PSYCHIATRICA SCANDINAVICA
    73. Jarventausta, K; Leinonen, E
      Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment

      ACTA PSYCHIATRICA SCANDINAVICA
    74. Bartenstein, P; Grunwald, F; Kuwert, T; Tatsch, K; Sabri, O; Benkert, O; Fahlbusch, R; Grunder, G; Herholz, K; Weiller, C
      Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    75. Leber, K; Malek, A; D'Agostino, A; Adelman, HM
      A veteran with acute mental changes years after combat

      HOSPITAL PRACTICE
    76. Clark, T; Rickards, H
      Catatonia 2: diagnosis, management and prognosis

      HOSPITAL MEDICINE
    77. Huang, TL; Ree, SC; Huang, YC; Liu, HY; Yang, YY
      Catatonic features: Differential diagnosis and treatments at an emergency unit

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    78. Oyewumi, LK; McKnight, M; Cernovsky, ZZ
      Lithium dosage and leukocyte counts in psychiatric patients

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    79. Szabadi, E; Tavernor, S
      Hypo- and hypersalivation induced by psychoactive drugs - Incidence, mechanisms and therapeutic implications

      CNS DRUGS
    80. Fink, M
      ECT in delirious states

      JOURNAL OF ECT
    81. Nisijima, K; Ishiguro, T
      Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: A report of five cases

      JOURNAL OF ECT
    82. Horwath, E; Cournos, F
      NMS and HIV

      PSYCHIATRIC SERVICES
    83. Marcus, EL; Vass, A; Zislin, J
      Marked elevation of serum creatine kinase associated with olanzapine therapy

      ANNALS OF PHARMACOTHERAPY
    84. Karagianis, JL; Phillips, LC; Hogan, KP; LeDrew, KK
      Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature

      ANNALS OF PHARMACOTHERAPY
    85. Brown, CS; Markowitz, JS; Moore, TR; Parker, NG
      Atypical antipsychotics: Part II - Adverse effects, drug interactions, andcosts

      ANNALS OF PHARMACOTHERAPY
    86. Lin, TJ; Hung, DZ; Hu, WH; Yang, DY; Wu, TC
      Acute basagran (TM) poisoning mimicking neuroleptic malignant syndrome

      HUMAN & EXPERIMENTAL TOXICOLOGY
    87. Walubo, A; Seger, D
      Fatal multi-organ failure after suicidal overdose with MDMA, 'Ecstasy': case report and review of the literature

      HUMAN & EXPERIMENTAL TOXICOLOGY
    88. Black, KJ; Mink, JW
      Neuropsychiatry of movement disorders

      CURRENT OPINION IN PSYCHIATRY
    89. Kasper, S; Hale, A; Azorin, JM; Moller, HJ
      Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    90. Nakahara, K; Tanaka, H; Masutani, K; Yanagida, T; Kashiwagi, M; Mizumasa, T; Masuda, K; Hirakata, H; Fujishima, M
      The value of computed tomography and magnetic resonance imaging to diagnose rhabdomyolysis in acute renal failure

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    91. Irizarry, MC; Ghaemi, SN; Lee-Cherry, ER; Gomez-Isla, T; Binetti, G; Hyman, BT; Growdon, JH
      Risperidone treatment of behavioral disturbances in outpatients with dementia

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    92. Tueth, MJ; Zuberi, P
      Life-threatening psychiatric emergencies in the elderly: Overview

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    93. Silva, RR; Munoz, DM; Alpert, M; Perlmutter, IR; Diaz, J
      Neuroleptic malignant syndrome in children and adolescents

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    94. Deep, P; Dagher, A; Sadikot, A; Gjedde, A; Cumming, P
      Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

      SYNAPSE
    95. Waldron, G; Schipperheijn, AJ
      The importance of isolated thrombocytopenia on routine blood screening in psychiatric patients

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    96. Lowson, SM; Sawh, S
      Adjuncts to analgesia - Sedation and neuromuscular blockade

      CRITICAL CARE CLINICS
    97. Adityanjee; Aderibigbe, YA; Mathews, T
      Epidemiology of neuroleptic malignant syndrome

      CLINICAL NEUROPHARMACOLOGY
    98. Iwahashi, K; Yoshihara, E; Nakamura, K; Ameno, K; Watanabe, M; Tsuneoka, Y; Ichikawa, Y; Igarashi, K
      CYP2D6 HhaI genotype and the neuroleptic malignant syndrome

      NEUROPSYCHOBIOLOGY
    99. Bauer, M; Zaninelli, R; Muller-Oerlinghausen, B; Meister, W
      Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    100. Stanford, BJ; Stanford, SC
      Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?

      JOURNAL OF PSYCHOPHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 03:24:46